Transdermal absorption of L-dopa from hydrogel in rats

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Neuroscience

Background:

• Levodopa (l-dopa) is a primary treatment for Parkinson's disease.
• Improving patient compliance with l-dopa administration is crucial.
• Transdermal drug delivery offers potential for sustained and controlled release.

Purpose of the Study:

• To investigate the transdermal absorption of l-dopa.
• To evaluate the efficacy of an alcoholic hydrogel formulation containing l-menthol for enhancing l-dopa penetration.
• To assess the in vivo impact of this formulation on neurotransmitter levels.

Main Methods:

• In vitro studies using two-chamber diffusion cells with excised rat abdominal skin.
• In vivo studies in rats utilizing an alcoholic hydrogel containing l-dopa and l-menthol.
• Measurement of plasma neurotransmitter levels (l-dopa, dopamine, norepinephrine, epinephrine).

Main Results:

• In vitro, l-menthol and ethanol significantly increased transdermal penetration of l-dopa.
• In vivo, the hydrogel formulation led to increased plasma levels of l-dopa and norepinephrine over time.
• Dopamine levels increased and plateaued, while epinephrine levels remained unchanged.

Conclusions:

• The developed hydrogel formulation effectively enhances transdermal l-dopa absorption.
• This formulation represents a promising new direction for the treatment of Parkinson's disease.
• Transdermal delivery may improve compliance and therapeutic outcomes for Parkinson's patients.